Core Biogenesis Competitors and Similar CompaniesClear all
Core Biogenesis's competitors and similar companies include NextCure and Elicio Therapeutics.
 Core Biogenesis Core Biogenesis is a biotech company developing a production platform to express recombinant proteins from plants. |  NextCure NextCure is a biopharmaceutical company focused on discovering and developing next-generation immuno-oncology-based drugs. |  Elicio Therapeutics Elicio Therapeutics (formerly known as Vedantra Pharmaceuticals) is an immuno-oncology company developing vaccines and immunotherapies for aggressive solid and hematologic cancers. | |
Founding Date | Founding Date 2020 | Founding Date 2015 | Founding Date 2011 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Paris, FR HQ Illkirch Graffenstaden, FR | Locations Beltsville, US HQ | Locations Cambridge, US HQ |
Employees | Employees 293% decrease | Employees N/A | Employees 22 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 39.2 m | Valuation ($) 47.5 m |
Financial | |||
Net income | Net income N/A | Net income ($55.8m) (FY, 2025) | Net income ($39.6m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 14.1m | Total funding raised $ 160m | Total funding raised $ 150.3m |
For sources of this data, please see the company profile
View Company Profiles
NextCure
HQ
Beltsville, US
NextCure is a biopharmaceutical company focused on discovering and developing next-generation immuno-oncology-based drugs.
View companyElicio Therapeutics
HQ
Cambridge, US
Employees
22
Elicio Therapeutics (formerly known as Vedantra Pharmaceuticals) is an immuno-oncology company developing vaccines and immunotherapies for aggressive solid and hematologic cancers.
View company